Pingora Partners LLC purchased a new position in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,600 shares of the company’s stock, valued at approximately $273,000. A number of other […]
DocuSign, Inc. (NASDAQ:DOCU – Get Free Report) shares fell 5.2% during mid-day trading on Thursday . The company traded as low as $55.40 and last traded at $55.45. 1,184,087 shares changed hands during mid-day trading, a decline of 58% from the average session volume of 2,821,354 shares. The stock had previously closed at $58.50. Wall […]
MUFG Securities EMEA plc raised its stake in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 10.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,456 shares of the company’s stock after purchasing an additional 950 shares during the quarter. MUFG […]
EverSource Wealth Advisors LLC Sells 238 Shares of DocuSign, Inc (NASDAQ:DOCU) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
DocuSign (NASDAQ:DOCU – Get Free Report) and Oncology Pharma (OTCMKTS:ONPH – Get Free Report) are both business services companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends. Volatility and Risk DocuSign has a beta of […]